Align Technology Profit Margin 2006-2018 | ALGN

Current and historical gross margin, operating margin and net profit margin for Align Technology (ALGN) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Align Technology net profit margin as of September 30, 2018 is 16.89%.
Align Technology Annual Profit Margins
Align Technology Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $17.542B $1.473B
Align Technology, Inc. is a global medical device company with industry-leading innovative products such as Invisalign clear aligners, iTero Intraoral scanners, and OrthoCAD digital services that help dental professionals achieve the clinical results they expect and deliver effective, cutting-edge dental options to their patients.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $62.744B 21.38
McKesson (MCK) United States $25.428B 9.71
AmerisourceBergen (ABC) United States $19.755B 14.09
Cardinal Health (CAH) United States $16.902B 11.35
Laboratory Of America Holdings (LH) United States $16.592B 15.02
Henry Schein (HSIC) United States $12.945B 21.28
Cooper (COO) United States $12.531B 22.57
DENTSPLY SIRONA (XRAY) United States $8.170B 16.32
West Pharmaceutical Services (WST) United States $7.920B 39.31
Merit Medical Systems (MMSI) United States $3.175B 37.60
Patterson (PDCO) United States $2.334B 16.41
CONMED (CNMD) United States $1.914B 31.79
STAAR Surgical (STAA) United States $1.889B 194.59
Atrion (ATRI) United States $1.348B 38.53
Antares Pharma (ATRS) United States $0.523B 0.00
Invacare (IVC) United States $0.220B 0.00
Lifevantage (LFVN) United States $0.173B 24.54
Endologix (ELGX) United States $0.104B 0.00
Pro-Dex (PDEX) United States $0.057B 25.60
Aceto (ACET) United States $0.053B 0.00
Biolase (BIOL) United States $0.029B 0.00
Retractable Technologies (RVP) United States $0.023B 0.00
Milestone Scientific (MLSS) United States $0.019B 0.00